Clinical Trial Update: Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of a solution used during endoscopic mucosal resection of colonic lesions has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms

Drugs mentioned

• Endoscopic Mucosal Resection solution

Snippet

Sponsor: Nakafarma S.L. | Conditions: Endoscopic Mucosal Resection, Colonic Neoplasms | Phase 3 | Status: COMPLETED